The Cantonal Hospital "Dr. Irfan Ljubijankić" in Bihać has concluded two contracts for the purchase of drugs intended for innovative oncological therapy, and a company from Mostar is among the selected suppliers. As the portal Jabuka.tv has learned, the hospital has concluded a contract for the purchase of the drug bevacizumab, in the form of ampoules, with the company Hercegovinalijek d.o.o. Mostar, worth 156,000 KM excluding VAT. The contract …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The Cantonal Hospital "Dr. Irfan Ljubijankić" in Bihać has concluded two contracts for the purchase of drugs intended for innovative oncological therapy, and a company from Mostar is among the selected suppliers. As the portal Jabuka.tv has learned, the hospital has concluded a contract for the purchase of the drug bevacizumab, in the form of ampoules, with the company Hercegovinalijek d.o.o. Mostar, worth 156,000 KM excluding VAT. The contract …